CCM
BMY icon

Carlson Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Carlson Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,261
Closed -$238K – 171
2022
Q1 		$238K Buy
+3,261
New +$219K 0.02% 149
2020
Q2 		– Sell
-4,484
Closed -$279K – 120
2020
Q1 		$279K Buy
+4,484
New +$274K 0.07% 82

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Carlson Capital Management's BMY Position: Q2 2022 in Review

Carlson Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 3,261 shares — an estimated $238K sold.

Carlson Capital Management first reported a position in BMY in Q1 2020 and held it in 2 quarters. The position peaked at $279K in Q1 2020. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Carlson Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
  • Carlson Capital Management sold 3,261 Bristol-Myers Squibb shares in Q2 2022, an estimated $238K.
  • Carlson Capital Management first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 2 quarters.
  • Carlson Capital Management's Bristol-Myers Squibb position peaked at $279K in Q1 2020.
  • 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Carlson Capital Management's 13F filing for Q2 2022, filed 18 Jul 2022.